S12 NONCLINICAL BIODISTRIBUTION CONSIDERATIONS FOR GENE THERAPY PRODUC
ICH - Safety
Drug Administration Guidance Issuing Office Docket Number Drug Evaluation Biologics Evaluation Biodistribution Considerations
Source: fda.gov
📰 Human Use News
Page 74 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
AB Science reports its revenues for the year 2022 and provides an update on its activities
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2022 AND THE KEY EVENTS OF THE PERIOD Financial information and other corporate... | April 28, 2023
France General United States Alain Moussy Health Canada Enforcement Committee Committee For Medicinal Products Human Use
Source: marketscreener.com
Positive CHMP opinion for UCB's bimekizumab
Therapy concerns the treatment of adults with axial spondyloarthritis and psoriatic arthritis - News - PharmaTimes
Northern Ireland United Kingdom Emmanuel Caeymaex European Medicines Agency Committee For Medicinal Products Human Use European Commission
Source: pharmatimes.com
European Union to streamline medicines regulatory process to speed up access for patients | Allen & Overy LLP
The European Union (EU) has just published its proposals to revise its general pharmaceutical legislation. One of the objectives of the revision is to reduce the regulatory burden on...
United States Allen Overy European Parliament European Commission Committee For Advanced Therapy Medicinal Products European Medicines Agency
Source: jdsupra.com
CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA
/PRNewswire/ -- Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agencys (EMA) Committee for...
Intrahepatic Cholangiocarcinoma Arndt Vogel Junko Onishi Europe Gmbh Zug Peter Foertig Takeshi Sagara
Source: prnewswire.com
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Paris , 27 April 2023Ipsen , a global specialty-driven biopharmaceutical company,... | April 27, 2023
Source: marketscreener.com
Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 27, 2023, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Revenue from... | April 27, 2023
Source: marketscreener.com
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa •    Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade •    Committee for Medicinal Products for Human Use (CHMP) opinion based...
United States Novartis Cosentyx Barry Mcgrath Hidradenitis Suppurativa Staedtisches Klinikum Dessau A Hidradenitis Suppurativa
Source: pharmiweb.com
Taiho Oncology Europe GmbH: CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA
ZUG, Switzerland, April 27, 2023 /PRNewswire/ -- Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agency's (EMA) Committee for Medicinal
Takeshi Sagara Arndt Vogel Intrahepatic Cholangiocarcinoma Europe Gmbh Zug Europe Gmb Judy Kay Moore
Source: finanznachrichten.de
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Reports First Quarter Revenues of $11.3 Billion Posts First Quarter GAAP Earnings Per Share of $1.07 and Non-GAAP EPS of $2.05; Includes Net Impact of Per Share for GAAP and Non-GAAP EPS Due to... | April 27, 2023
Source: marketscreener.com